ReviewJournal of inflammation research2026
Emerging Insights into the Inflammatory Phenotypes of Eosinophilic Esophagitis.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Eosinophilic Esophagitis (EoE) is an immune-mediated disease associated with pronounced Type 2 allergic inflammation. Here we review the literature addressing the cellular and molecular mechanisms that drive inflammation in EoE, and the consequences of inflammation for epithelial damage and fibrotic remodeling. Emerging data identifies the dynamic interplay of a complex network of cytokines and immune cells that orchestrate EoE related inflammation. Significant insight into inflammatory cascades achieved through preclinical studies using cultured human cells and mouse models collectively underscores the interplay of IL-5, IL-13, and eotaxin in mucosal remodeling, immune cell recruitment, and activation. Although questions remain surrounding the specific initiating factors in EoE onset, evidence exists for involvement of environmental allergens or chemical irritants that damage the epithelium and trigger release of inflammatory alarmins including IL-33, which in turn activate resident mast cells and lymphocytes to secrete Type 2 cytokines. In addition to immune cells, the basal epithelium and lamina propria fibroblasts are particularly important to the inflammatory cascade, as they secrete additional cytokines when stimulated with IL-13. Improved understanding of the complex intercellular dynamics within the inflamed esophagus through next-generation single-cell sequencing and molecular studies are poised to identify the critical features of the inflamed esophagus, address tissue changes in response to steroid or biologic treatment, and determine when and how chronic inflammation may progress to fibrostenotic remodeling to identify novel therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.